A recent advance in custom-designed, cell-free translation systems that makes use of purified and recombinant components opens up new perspectives for synthesizing non-natural translation products. Combining these systems with chemically engineered ribosomes sets the stage for novel synthetic biology projects.
No takes yet. Share an insight, caveat, or question.
Norbert Polacek (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: